在卵巢小细胞癌中,MYC调节DNA修复基因表达程序,超血型卵巢癌
James R Evans1,2, Jing Wang3,4, Cinthia N Reed1,2
1Department of Biology, Middle Tennessee State University, Murfreesboro, TN 37132, USA.
Cancers
|July 12, 2025
概括
MYC驱动小细胞卵巢癌 (SCCOHT) 中的DNA修复基因表达,这是一种与SWI/SNF突变相关的癌症. 恢复BRG1可以抵消这种MYC程序,为SCCOHT提供治疗点.
科学领域:
- 在瘤学瘤学.
- 癌症基因组学 癌症基因组学
- 染色体重塑 染色体重塑 的方法
背景情况:
- 卵巢小细胞癌,高血型 (SCCOHT) 是一种侵袭性癌症,通常是由SWI/SNF染色体重塑复杂基因的突变驱动的,例如SMARCA4.
- SMARCA4突变会损害SWI/SNF功能,可能会影响像MYC这样的瘤性途径,这种途径在SWI/SNF突变癌症中经常被激活.
研究的目的:
- 调查MYC在SCCOHT生物学中的作用.
- 探索SWI/SNF (特别是BRG1) 和MYC在SCCOHT中调节基因表达和DNA修复中的相互作用.
主要方法:
- 利用基因工程SCCOHT细胞系进行染色体结合和转录组测试.
- 使用患者瘤表达数据进行验证.
- 研究了MYC枯竭和BRG1重新引入对基因表达的影响.
主要成果:
- MYC与SCCOHT细胞中的许多活性促进体结合.
- MYC 枯竭大大改变了基因表达,特别是影响了DNA修复基因.
- 确定了一种MYC驱动的DNA修复基因表达程序,该程序被BRG1.1抑制.
- 在SCCOHT瘤和SWI/SNF缺陷瘤中,DNA修复基因特征被上调.
结论:
- 在SCCOHT中,MYC是DNA修复基因表达的重要调节者.
- 这些发现突出了BRG1和MYC在SCCOHT瘤发生过程中的潜在功能关系.
- 这项研究为进一步研究BRG1-MYC相互作用和SCCOHT的治疗策略提供了基础.
关键词:
这是一个ATRATRATRATR.这就是BRG1的原因.修复DNA的修复DNA的修复我的世界 MYC斯科特 (SCCOHT) 是一个小岛屿.这就是SMARCA4的标志.在SNF5中,SNF5是SNF5.在 SWI/SNF 中.卵巢 卵巢 的 卵巢这种瘤是rhabdoid瘤.更多相关视频
09:08Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer
Published on: January 12, 2020
6.8K
10:27Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
7.4K
相关概念视频
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Induced Pluripotent Stem Cells
4.4K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
4.4K
Epigenetic Regulation
3.1K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.1K
DNA Damage can Stall the Cell Cycle
9.3K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.3K
Negative Regulator Molecules
36.1K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
36.1K
mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
